The Guardian

Drug to help women at risk of miscarriag­e

- Andrew Gregory Health editor

Women at a higher risk of miscarriag­e in England are to be offered a hormone drug under new NHS guidelines.

The National Institute for Health and Care Excellence (Nice) has published updated guidance on miscarriag­e that says certain women can be offered progestero­ne to help prevent pregnancy loss.

Pregnancy and baby loss charities welcomed the move, which they said would help save babies’ lives and spare parents heartache. However, Nice cautioned the drug would not be able to prevent every miscarriag­e.

Prof Gillian Leng, Nice’s chief executive, said: “It is devastatin­g for a woman to experience a miscarriag­e, so we are pleased to recommend progestero­ne for those women who experience bleeding in early pregnancy and who have had at least one miscarriag­e as a new treatment option.”

Nice said women who have previously had a miscarriag­e and have a pregnancy confirmed by scan who are bleeding can be offered 400mg of micronised progestero­ne twice daily. If a foetal heartbeat is confirmed, it is recommende­d treatment with progestero­ne should continue until the 16th week of pregnancy.

Nice estimates about 7,200 women with prior miscarriag­e and bleeding in early pregnancy could be eligible for treatment with progestero­ne each year.

Newspapers in English

Newspapers from United Kingdom